Pharmabiz

Strides to launch potassium chloride ER tablets in US market

Strides Pharma Science’s wholly owned subsidiary, Vensun Pharmaceuticals, Inc., USA and its partner Pharmaceutics International, Inc. (Pii) have received approval from the United States Food & Drug ...
Business Wire

Vitruvias Therapeutics Inc., Licenses Potassium Chloride ER ANDA (10 and 20 mEq) Capsules to Be Manufactured at Bora Pharmaceutical’s New Zhunan Facility in Taiwan

AUBURN, Ala. & TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium ...
Pharmabiz

Zydus Cadila receives US FDA approval for potassium chloride ER tablets

Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market potassium chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg).
USA Today

Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution

Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is being ...
WFTV

ICU Medical Issues Nationwide Recall of Potassium Chloride Injection, 20 mEq and Potassium Chloride Injection, 10 mEq Due to Mislabeling

ICU Medical, Inc. is voluntarily recalling one lot each of POTASSIUM CHLORIDE Inj. bags with overwrap labels 10mEq, packaged in cases of POTASSIUM CHLORIDE Inj. 20 mEq, to the user level. ICU medical ...
Mena FN

Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall For Potassium Chloride Extended-Release Capsules, USP (750 Mg) 10 Meq K Due To Failed Dissolution

is notifying its wholesale and distributor customers by written letters and is arranging for return of all recalled batches. Wholesalers, distributors, and retailers that have the recalled products ...